Larvol Veri

BIOMARKER:

NRG1 mutation

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

NRG1 mutation NRG1 mutation	Squamous Cell Carcinoma of Head and Neck SCCHN	cetuximab + ISU104 Sensitive: C3 – Early Trials cetuximab + ISU104 Sensitive : C3
NRG1 mutation NRG1 mutation	Pancreatic Cancer Pancreatic Cancer	afatinib + pertuzumab Sensitive: C3 – Early Trials afatinib + pertuzumab Sensitive : C3
NRG1 mutation NRG1 mutation	Pancreatic Cancer Pancreatic Cancer	erlotinib + pertuzumab Sensitive: C3 – Early Trials erlotinib + pertuzumab Sensitive : C3